Lyell Immunopharma, Inc. — 4 Filings
111 4 filings on record
This page lists all 4 filings submitted to the SEC by Lyell Immunopharma, Inc. (LYEL), sorted by most recent first. Each row links to the full filing on EdgarLookup. Lyell Immunopharma, Inc. has filed 111 4 documents with the SEC since 2020. To view all SEC filings by Lyell Immunopharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001808821-26-000006 | Mar 16, 2026 | Mar 9, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000234 | Mar 9, 2026 | Mar 6, 2026 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000235 | Mar 9, 2026 | Mar 6, 2026 |
| 4 | — | 0001907345-26-000002 | Feb 12, 2026 | Feb 11, 2026 |
| 4 | — | 0001866154-26-000002 | Feb 12, 2026 | Feb 11, 2026 |
| 4 | — | 0001327111-26-000002 | Feb 12, 2026 | Feb 11, 2026 |
| 4 | — | 0001866154-26-000001 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0002095702-26-000002 | Feb 11, 2026 | Feb 10, 2026 |
| 4 | — | 0001771329-26-000001 | Feb 11, 2026 | Feb 10, 2026 |
| 4 | — | 0001959742-26-000001 | Feb 11, 2026 | Feb 10, 2026 |
| 4 | — | 0001907345-26-000001 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0001327111-26-000001 | Feb 11, 2026 | Feb 9, 2026 |
| 4 | — | 0002095702-26-000001 | Jan 6, 2026 | Dec 24, 2025 |
| 4 | — | 0002095702-25-000003 | Nov 12, 2025 | Nov 10, 2025 |
| 4 | — | 0001907345-25-000006 | Nov 12, 2025 | Nov 10, 2025 |
| 4 | — | 0001327111-25-000007 | Nov 12, 2025 | Nov 10, 2025 |
| 4 | — | 0001866154-25-000006 | Nov 12, 2025 | Nov 10, 2025 |
| 4 | — | 0001907345-25-000005 | Oct 29, 2025 | Oct 27, 2025 |
| 4 | — | 0001866154-25-000005 | Oct 29, 2025 | Oct 27, 2025 |
| 4 | — | 0001327111-25-000006 | Oct 29, 2025 | Oct 27, 2025 |
| 4 | — | 0001415889-25-022740 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022747 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022741 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-022746 | Aug 22, 2025 | Aug 20, 2025 |
| 4 | — | 0001415889-25-021694 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021691 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021693 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | — | 0001415889-25-021692 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013262 | Jul 29, 2025 | Jul 25, 2025 |
| 4 | — | 0001415889-25-016729 | Jun 11, 2025 | Jun 9, 2025 |
| 4 | — | 0001415889-25-016728 | Jun 11, 2025 | Jun 9, 2025 |
| 4 | — | 0001415889-25-016730 | Jun 11, 2025 | Jun 9, 2025 |
| 4 | — | 0001415889-25-013723 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013710 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013707 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013712 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013719 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013705 | May 19, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-009604 | Apr 2, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-008942 | Mar 25, 2025 | Mar 21, 2025 |
| 4 | — | 0001415889-25-008517 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | — | 0001415889-25-008540 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | — | 0001415889-25-008509 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | — | 0001415889-25-005747 | Feb 26, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-25-005775 | Feb 26, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-25-005753 | Feb 26, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-25-005760 | Feb 26, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-25-005768 | Feb 26, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-24-025912 | Nov 1, 2024 | Oct 31, 2024 |
| 4 | — | 0001415889-24-017220 | Jun 17, 2024 | Jun 14, 2024 |